$QURE 4/A SEC Filings

Filed On	Filing
21 Feb 2017	Form 4/A: Petry Harald, Chief Scientific Officer Granted 43,000 Stock Option (Right to Buy) · Granted 43,500 Performance Share Unit
21 Feb 2017	Form 4/A: Meyer Christian, Chief Medical Officer Granted 43,000 Stock Option (Right to Buy) · Granted 43,500 Preformance Share Unit
21 Feb 2017	Form 4/A: Keson-Brookes Maiken, General Counsel Granted 43,000 Stock Option (Right to Buy) · Granted 43,500 Performance Share Unit
21 Feb 2017	Form 4/A: Garen Jonathan, Chief Business Officer Granted 43,000 Stock Option (Right to Buy) · Granted 43,500 Performance Share Unit
21 Feb 2017	Form 4/A: Firuta Paul E, Chief Commercial Officer Granted 43,000 Stock Option (Right to Buy) · Granted 43,500 Preformance Share Unit
21 Feb 2017	Form 4/A: Cantor Maria E, SVP, Investor Relations Granted 43,000 Stock Option (Right to Buy) · Granted 43,500 Preformance Share Unit

Comments